[1]
E. Santinelli, “Long-term persistence of dysplastic features in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide”, Mediterr J Hematol Infect Dis, vol. 17, no. 1, p. e2025038, Apr. 2025.